AngioDynamics (ANGO) delivered earnings and revenue surprises of +28.57% and +4.75%, respectively, for the quarter ended August 2025. Do the numbers...
Vous n'êtes pas connecté
AngioDynamics posts narrower-than-expected Q1 loss, 12% revenue growth and margin gains; it also raises FY26 sales outlook, sending shares higher.
AngioDynamics (ANGO) delivered earnings and revenue surprises of +28.57% and +4.75%, respectively, for the quarter ended August 2025. Do the numbers...
J.M. Smucker's coffee business fuels gains in Q1, driving a higher FY26 sales outlook despite cost and tariff pressures.
APOG beats Q2 earnings and revenue estimates on UW Solutions gains but trims its FY26 outlook amid margin pressure.
NKE tops Q1 revenue and EPS forecasts, but warns of tariff-driven margin pressure and a Q2 sales decline ahead.
PEP posts Q3 earnings and revenue beats as innovation and cost optimization fuel steady global growth despite margin pressure.
Applied Digital (NASDAQ: APLD) rallied more than 20% this morning after posting blockbuster financials for its first quarter that came in well above...
MKC posts a Q3 earnings and sales beat but trims its 2025 profit outlook as rising tariffs and input costs weigh on margins.
CAG's first-quarter earnings and sales beat estimates, but year-over-year declines highlight pressure from lower volumes and margin contraction.
DAL's Q3 results are expected to show steady revenue growth and cost control, but inflation and weak travel demand could cloud the outlook.
DAL's Q3 results are expected to show steady revenue growth and cost control, but inflation and weak travel demand could cloud the outlook.